Ventricular Assist Devices Market 2020 Global Research On Latest Developments by key players, Segmentation And Opportunities Forecast To 2027
Ventricular assist device (VAD) is used to assist a damaged or weakened heart in pumping blood. The device is surgically attached to one or both intact ventricles and thus assists cardiac circulation.
Download Sample PDF Of Report@ https://www.alliedmarketresearch.com/request-sample/2024
According to a new report published by Allied Market Research titled "Ventricular Assist Devices Market by Product (Left Ventricular Assist Device [LVAD], Right Ventricular Assist Device [RVAD], and Biventricular Assist Device [BIVAD]), Application (Bridge-to-transplant [BTT] Therapy, Destination Therapy, Bridge-to-recovery [BTR] Therapy, and Bridge-to-candidacy [BTC] Therapy), and Design (Transcutaneous Ventricular Assist Device and Implantable Ventricular Assist Device) - Global Opportunity Analysis and Industry Forecast, 2020-2027
Global Market Size of Ventricular Assist Devices Market is $XX million in 2019 with XX CAGR, and it is expected to reach $XX million by the end of 2027 with a CAGR of XX% from 2020 to 2027.
The report lays emphasis on the key trends and opportunities that may emerge in the near future and positively impact the overall industry growth. Additionally, challenges and restraining factors that are likely to curb the growth in the years to come are put forth by the analysts to prepare the manufacturers for future challenges in advance.
The major companies profiled in the report are Abiomed, Inc., Asahi Kasei Corporation (Evaheart Medical U.S.A., Inc.), Abbott Laboratories (St. Jude Medical, Inc.), Berlin Heart GmbH, Calon Cardio-Technology Ltd., CardiacAssist Technologies, Jarvik Heart, Inc., Medtronic plc, ReliantHeart, Inc., and Terumo Medical Corporation.
Asia-Pacific market is projected to grow at the highest CAGR during the forecast period, owing to increase in awareness about the benefits of digital wound measurement devices in healthcare industry and rise in expenditures in emerging markets (such as India and China) to cater to the unmet medical needs.
Key Benefits Of Report:-
o The study provides an in-depth analysis of the global ventricular assist devices market, with current trends and future estimations to elucidate the imminent investment pockets.
o Quantitative analysis from 2020 to 2027 is expected to enable the stakeholders to capitalize on prevailing market opportunities.
o Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
o Extensive analysis is conducted by closely following key product positioning and monitoring the top contenders within the market framework.
By product, LVADs accounted for the major share of the global ventricular assist devices market in 2016. By application segment, bridge-to-transplant generated the maximum revenue, thus accounting for more than 49% of the global ventricular assist devices market in 2016. In addition, destination therapy segment is expected to witness the highest CAGR of 13.4% during the forecast period. By design, implantable ventricular assist device dominated the market with three-fourths share in the global ventricular assist devices market in 2016.
Enquiry Before Buying@ https://www.alliedmarketresearch.com/purchase-enquiry/2024
5933 NE Win Sivers Drive
#205, Portland, OR 97220
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
This release was published on openPR.
Permanent link to this press release:
You can edit or delete your press release Ventricular Assist Devices Market 2020 Global Research On Latest Developments by key players, Segmentation And Opportunities Forecast To 2027 here
News-ID: 1925955 • Views: 558
More Releases from Allied Market Research
North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently
More Releases for Assist
Walking Assist Device
The Walking Assist Device Market 2018 Industry Research Report focused on global and regional market, major manufacturers, as well as the current state of the Walking Assist Devicese industry. First, " Walking Assist Devicese Industry 2018" report analyzed the basic scope of this industry like definition, specification, classification, application, industry policy, news analysis and Walking Assist Devicese industry chain structure. Walking Assist Device Market Top Players Honda Motor Co., Ltd., Permobil
Cardiac Assist Devices Market: Ventricular Assist Devices to Register the Fastes …
Global Cardiac Assist Devices Market: Snapshot A cardiac assist device is an electromechanical device for assisting cardiac circulation, which is used either partially or to completely replace the function of a failing heart. A new research report by Future Market Insights highlights the changing scenario of the global cardiac assist devices market given the increase in cases of cardiovascular diseases across the world. The report is titled ‘Cardiac Assist Devices Market:
Automotive Intelligence Park Assist System Market: Demand for Semiautonomous Par …
The significant increase in the traffic flow, leading to a substantial rise in the number of road accidents, is influencing the global market for automotive intelligent park assist systems remarkably. With the increasing concerns among people over safety and comfort across the world, the automobile manufacturers are encouraged to combine automotive intelligent park assist systems into their vehicles, resulting the considerable rise in the demand for automotive intelligent park assist
Mexico Cardiac Assist Devices
Mexico Cardiac Assist Devices Overview "Mexico Cardiac Assist Devices Market Outlook to 2025", provides key market data on the Mexico Cardiac Assist Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Intra-Aortic Balloon Pumps, Total Artificial Heart and Ventricular Assist Devices. Click here for sample report @ https://www.wiseguyreports.com/sample-request/3107735-mexico-cardiac-assist-devices-market-outlook-to-2025 Major Key Players: Abbott Laboratories Medtronic plc Getinge AB. Major Highlight of the report: The report also provides
Automotive Intelligence Park Assist System Market: Demand for Semiautonomous Par …
With each of the region led by a select numbers of players, the global automotive intelligence park assist systems market demonstrates a highly consolidated structure. Although the degree of competition within this market will significantly high over the next few years, thanks to the presence of medium and large sized manufacturers in a large number, states a new report by Transparency Market Research (TMR). Toshiba Corp., Hitachi Ltd., Robert Bosch
Ventricular Assist Devices (VAD) Market Assessment
Ventricular assist devices (VAD) are mechanical pumps used to support patients with a weakened heart or in case of heart failure to temporarily maintain heart function. The devices helps in re-establishing normal hemodynamics under conditions involving damaged ventricle. Increasing trend for sedentary lifestyle, rising obesity population globally, lifestyle changes and various other factors have resulted an increase in cardiovascular disorders. This rising prevalence across the globe has been a major